PanayiotisSSavvidesMD

Clinical Trials

• Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Start of enrollment: 2002 Sep 01

  Completed

  Phase 1

• Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer Start of enrollment: 2003 Feb 01

  Completed

  Phase 2

• Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer Start of enrollment: 2003 Nov 01

  Terminated

  Phase 1, Phase 2

• Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma Start of enrollment: 2004 Dec 01

  Withdrawn

  Not Applicable

• Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2005 Sep 01

  Completed

  Phase 2

• Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors Start of enrollment: 2005 Nov 01

  Completed

• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08

  Active, not recruiting

  Phase 3

• Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Jan 01

  Completed

  Phase 3

• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2007 Nov 01

  Completed

  Phase 2

• Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors Start of enrollment: 2007 Aug 16

  Completed

  Phase 1

• Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck Start of enrollment: 2011 Jan 01

  Terminated

  Phase 2

• Lapatinib With Carboplatin and Paclitaxel in Esophagus and Gastroesophageal Junction (GEJ) Start of enrollment: 2011 Aug 01

  Terminated

  Phase 1, Phase 2

• Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Apr 14

  Completed

  Phase 1

• Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer Start of enrollment: 2021 Jul 23

  Recruiting

  Phase 2

• Join now to see all